Gujarat Themis Biosyn Ltd. has formed a wholly owned Japan subsidiary, Themis Biosyn Japan Limited, as of 19 May 2026, with 100% ownership and initial share capital of Yen 10 Lakhs, marking geographic expansion in the pharmaceutical space.
AI Assistant
Gujarat Themis Biosyn Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.